Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.33 USD | +3.10% | +0.76% | -11.33% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.33% | 63.27M | |
-1.03% | 104B | |
+5.52% | 97.47B | |
+5.71% | 22.25B | |
-13.30% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.42% | 16.36B | |
+8.69% | 14.39B | |
+40.00% | 12.37B |
- Stock Market
- Equities
- MNOV Stock
- News MediciNova, Inc.
- MediciNova Says Glioblastoma Phase 2 Trial of Therapy Combo Showed Progression-Free Survival of 44% at Six Months